Cardiomyocyte maturation alters molecular stress response capacities and determines cell survival upon mitochondrial dysfunction

dc.contributor.authorSchraps, Nina
dc.contributor.authorTirre, Michaela
dc.contributor.authorPyschny, Simon
dc.contributor.authorReis, Anna
dc.contributor.authorSchlierbach, Hannah
dc.contributor.authorSeidl, Matthias
dc.contributor.authorKehl, Hans-Gerd
dc.contributor.authorSchänzer, Anne
dc.contributor.authorHeger, Jacqueline
dc.contributor.authorJux, Christian
dc.contributor.authorDrenckhahn, Jörg-Detlef
dc.date.accessioned2025-11-18T08:57:56Z
dc.date.available2025-11-18T08:57:56Z
dc.date.issued2024
dc.description.abstractCardiomyocyte maturation during pre- and postnatal development requires multiple intertwined processes, including a switch in energy generation from glucose utilization in the embryonic heart towards fatty acid oxidation after birth. This is accompanied by a boost in mitochondrial mass to increase capacities for oxidative phosphorylation and ATP generation required for efficient contraction. Whether cardiomyocyte differentiation is paralleled by augmented capacities to deal with reactive oxygen species (ROS), physiological byproducts of the mitochondrial electron transport chain (ETC), is less clear. Here we show that expression of genes and proteins involved in redox homeostasis and protein quality control within mitochondria increases after birth in the mouse and human heart. Using primary embryonic, neonatal and adult mouse cardiomyocytes in vitro we investigated how excessive ROS production induced by mitochondrial dysfunction affects cell survival and stress response at different stages of maturation. Embryonic and neonatal cardiomyocytes largely tolerate inhibition of ETC complex III by antimycin A (AMA) as well as ATP synthase (complex V) by oligomycin but are susceptible to complex I inhibition by rotenone. All three inhibitors alter the intracellular distribution and ultrastructure of mitochondria in neonatal cardiomyocytes. In contrast, adult cardiomyocytes treated with AMA undergo rapid morphological changes and cellular disintegration. At the molecular level embryonic cardiomyocytes activate antioxidative defense mechanisms, the integrated stress response (ISR) and ER stress but not the mitochondrial unfolded protein response upon complex III inhibition. In contrast, adult cardiomyocytes fail to activate the ISR and antioxidative proteins following AMA treatment. In conclusion, our results identified fundamental differences in cell survival and stress response in differentiated compared to immature cardiomyocytes subjected to mitochondrial dysfunction. The high stress tolerance of immature cardiomyocytes might allow outlasting unfavorable intrauterine conditions thereby preventing fetal or perinatal heart disease and may contribute to the regenerative capacity of the embryonic and neonatal mammalian heart.en
dc.identifier.urihttps://jlupub.ub.uni-giessen.de/handle/jlupub/21047
dc.identifier.urihttps://doi.org/10.22029/jlupub-20396
dc.language.isoen
dc.rightsNamensnennung - Nicht kommerziell 4.0 International
dc.rights.urihttps://creativecommons.org/licenses/by-nc/4.0/
dc.subject.ddcddc:610
dc.titleCardiomyocyte maturation alters molecular stress response capacities and determines cell survival upon mitochondrial dysfunction
dc.typearticle
local.affiliationFB 11 - Medizin
local.source.epage265
local.source.journaltitleFree radical biology and medicine
local.source.spage248
local.source.urihttps://doi.org/10.1016/j.freeradbiomed.2024.01.034
local.source.volume213

Dateien

Originalbündel

Gerade angezeigt 1 - 1 von 1
Lade...
Vorschaubild
Name:
10.1016_j.freeradbiomed.2024.01.034.pdf
Größe:
16.17 MB
Format:
Adobe Portable Document Format